{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:02:53Z","timestamp":1789455773304,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (R0I AG 11380)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG11380"],"award-info":[{"award-number":["R01 AG11380"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.neurobiolaging.2014.05.002","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T11:04:55Z","timestamp":1399633495000},"page":"2429-2435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-9855","authenticated-orcid":false,"given":"Yi-Fang","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.S.","family":"Breitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ling","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara","family":"Khachaturian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn","family":"Tschanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Munger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Welsh-Bohmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib1","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","article-title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies","volume":"10","author":"Anderson","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-iii-r","year":"1987"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-2008-15213","article-title":"Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?","volume":"15","author":"Becker","year":"2008","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.324.7339.699","article-title":"Use of ramipril in preventing stroke: double blind randomised trial","volume":"324","author":"Bosch","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.53.2.321","article-title":"APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study","volume":"53","author":"Breitner","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrd3461","article-title":"Mining for therapeutic gold","volume":"10","author":"Collins","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","volume":"7","author":"Diener","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jalz.2012.02.002","article-title":"Improving Alzheimer's disease phase II clinical trials","volume":"9","author":"Greenberg","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.56.8.991","article-title":"Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use","volume":"56","author":"Guo","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/01.wnl.0000345062.86148.3f","article-title":"Duration of antihypertensive drug use and risk of dementia: a prospective cohort study","volume":"72","author":"Haag","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib13","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0895-4356(03)00247-6","article-title":"Characteristics of a two-stage screen for incident dementia","volume":"56","author":"Hayden","year":"2003","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(00)00241-4","article-title":"Antihypertensive drugs and incidence of dementia: the Rotterdam Study","volume":"22","author":"in't Veld","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1017\/S0033291700005742","article-title":"The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms","volume":"19","author":"Jorm","year":"1989","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: the Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib17","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib18","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.wad.0000201848.67954.7d","article-title":"Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life","volume":"20","author":"Mielke","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib22","series-title":"NIH-Industry Roundtable: Exploring New Uses for Abandoned and Approved Therapeutics","year":"2011"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1532-5415.2004.52178_7.x","article-title":"Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan","volume":"52","author":"Ohrui","year":"2004","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1532-5415.2012.04061.x","article-title":"Self-reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: the Hisayama Study","volume":"60","author":"Ozawa","year":"2012","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jalz.2005.11.001","article-title":"Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples","volume":"2","author":"Plassman","year":"2006","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/WNL.58.8.1175","article-title":"The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function","volume":"58","author":"Posner","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/2.2.159","article-title":"Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes\/swabs","volume":"2","author":"Richards","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jalz.2011.09.226","article-title":"Countrywide strategic plans on Alzheimer's disease: developing the framework for the international battle against Alzheimer's disease","volume":"7","author":"Rosow","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib30","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1176\/ajp.143.10.1279","article-title":"Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias","volume":"143","author":"Silverman","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1179\/016164106X130506","article-title":"Update on hypertension and Alzheimer's disease","volume":"28","author":"Skoog","year":"2006","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib33","first-page":"314","article-title":"The Modified Mini-Mental State (3MS) examination","volume":"48","author":"Teng","year":"1987","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib34","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib35","first-page":"28","article-title":"An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the cache county study","volume":"15","author":"Tschanz","year":"2002","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib36","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.54.6.1290","article-title":"Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study","volume":"54","author":"Tschanz","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","article-title":"Antihypertensive drugs decrease risk of Alzheimer disease: ginkgo evaluation of memory study","volume":"81","author":"Yasar","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.05.002_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2013.01.053","article-title":"Potassium 2-(1-hydroxypentyl)-benzoate improves learning and memory deficits in chronic cerebral hypoperfused rats","volume":"541","author":"Zhao","year":"2013","journal-title":"Neurosci. Lett."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014003406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014003406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T04:22:30Z","timestamp":1538626950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014003406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0197458014003406"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.05.002","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}